Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Apellis Pharmaceuticals, Inc.
| Metric | Apellis Pharmaceuticals, Inc. APLSHealthcare |
|---|---|
| Quality Score | 83 / 100 |
| Revenue (latest) | $1.00B |
| Net income (latest) | $22M |
| Operating margin | 5.5% |
| Net margin | 2.2% |
| Return on equity | 6.0% |
| Return on assets | 2.1% |
| Return on capital (ROCE) | 7.4% |
| Debt / equity | 1.90× |
| Revenue growth (YoY) | 28.5% |
| Altman Z″ (distress) | -4.02 |
| Accruals / assets | −2.1% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.